Catalog: | C0826T |
Product Type: | Test kit |
Unit: | 96 tests |
Regulatory status: | EU: CE |
Incubation time: | 1 x 1h, 1 x 30 min, 1 x 20min |
Standard range: | 0.2 - 16 ng/Ml |
Sample type: | Serum, plasma |
Sample requirements: | 100 µL |
Isotope/Substrate: | TMB 450 nm |
Analysis mode: | ELISA |
Application: | Metabolic Syndrome |
C-Peptide levels are a more stable indicator of insulin secretion than the more rapidly changing levels of insulin. A very clear practical advantage of C-Peptide measurement arising from its relative metabolic inertness as compared to insulin is that C-Peptide levels in peripheral venous blood are about 5-6 times greater than insulin levels. Also, relative to an insulin assay, the C-Peptide assay's advantage is its ability to distinguish endogenous from injected insulin. C-Peptide levels are in many ways a better measurement of endogenous insulin secretion than peripheral insulin levels. C-Peptide may be measured in either blood or urine. With improved sensitive C-Peptide immunoassays, it is now possible to measure C-Peptide values at extremely low levels.
Copyright © 2024 Creative Biogene. All rights reserved.